PP89. THE MOLECULAR ANALYSIS OF MUTATIONS IN SMN, NAIP AND TGFB GENES IN ROMANIAN SMA PATIENTS
P APOSTOL1, D Cimponeriu1, N Butoianu2, M Stavarachi1, M Toma1, Sanda Magureanu2, Lucian Gavrila1 1. Institute of Genetics, University of Bucharest, Romania 2. Departament of Pediatrics Neurology I, "Alexandru Obregia" Hospital, Bucharest, Romania e-mail: apostol_pompilia@yahoo.com
*Corresponding Author:
page: 87

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive disorder characterized by degeneration of lower motor neurons. In Romania, no statistical data regarding the incidence of disease are available. Survival motor neuron (SMN - 5q12.2-13.3) is the SMA-determining gene. The severity of SMA clinical signs may be influenced by modifier genes: SMN2, NAIP (5q12.2-13.3) and TGFb (19q13.1).

Aims: 1) to implement the molecular tests for assessing mutations in the SMN and NAIP genes in Romania and 2) to estimate the frequency of two common biallelic markers in the promoter region of TGFb gene in SMA patients and in general population.

Subjects: SMA patients (n=43), their parents (n=40) and healthy persons (n=100).

Genomic analysis. All subjects were screened for the SMN genes exons 7 and 8 deletion by PCR-RFLP, for the NAIP exon 5 deletion by PCR and for TGFb -800GA and -509CT polymorphisms by SSP-PCR.

Results and discussions: the homozygous deletion of exons 7 and 8 of the SMN1 gene was observed in 71,11% SMA patients while the NAIP exon 5 deletion was identified only in 17,7% SMA patients. The frequency of TGFb genotypes for the three groups is listed in Table 1. The Hardy-Weinberg equilibrium is respected only for the -800GA polymorphism.

Conclusions: This is the first test available in Romania for the SMA molecular diagnosis. The highest frequency of mutations was identified in SMN1 gene in SMA patients. The mutations in NAIP gene and the TGFb polymorphisms could have a modifier effect on clinical evolution of disease.

 

Table 1.

 

Lot

TGFb -800GA

TGFb -509CT

GG

GA

AA

CC

CT

TT

Patients

86,05%

13, 95%

0%

6,98%

88,37%

4,65%

Parents

77,5%

22,5%

0%

90%

2,5%

7,5%

Control

75,24%

23,76%

0,99%

27,72%

64,35%

7,92%

 




Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006